» Articles » PMID: 34228239

CCN Proteins in the Musculoskeletal System: Current Understanding and Challenges in Physiology and Pathology

Overview
Date 2021 Jul 6
PMID 34228239
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The acronym for the CCN family was recently revised to represent "cellular communication network". These six, small, cysteine-enriched and evolutionarily conserved proteins are secreted matricellular proteins, that convey and modulate intercellular communication by interacting with structural proteins, signalling factors and cell surface receptors. Their role in the development and physiology of musculoskeletal system, constituted by connective tissues where cells are interspersed in the cellular matrix, has been broadly studied. Previous research has highlighted a crucial balance of CCN proteins in mesenchymal stem cell commitment and a pivotal role for CCN1, CCN2 and their alter ego CCN3 in chondrogenesis and osteogenesis; CCN4 plays a minor role and the role of CCN5 and CCN6 is still unclear. CCN proteins also participate in osteoclastogenesis and myogenesis. In adult life, CCN proteins serve as mechanosensory proteins in the musculoskeletal system providing a steady response to environmental stimuli and participating in fracture healing. Substantial evidence also supports the involvement of CCN proteins in inflammatory pathologies, such as osteoarthritis and rheumatoid arthritis, as well as in cancers affecting the musculoskeletal system and bone metastasis. These matricellular proteins indeed show involvement in inflammation and cancer, thus representing intriguing therapeutic targets. This review discusses the current understanding of CCN proteins in the musculoskeletal system as well as the controversies and challenges associated with their multiple and complex roles, and it aims to link the dispersed knowledge in an effort to stimulate and guide readers to an area that the writers consider to have significant impact and relevant potentialities.

Citing Articles

Biallelic variants in CCN2 underlie an autosomal recessive kyphomelic dysplasia.

Singh S, Danda S, Sharma N, Shah H, Madhuri V, Mir T Eur J Hum Genet. 2024; 33(1):30-37.

PMID: 39506047 PMC: 11711675. DOI: 10.1038/s41431-024-01725-5.


A monoallelic variant in CCN2 causes an autosomal dominant spondyloepimetaphyseal dysplasia with low bone mass.

Li S, Shao R, Li S, Zhao J, Deng Q, Li P Bone Res. 2024; 12(1):60.

PMID: 39414788 PMC: 11484961. DOI: 10.1038/s41413-024-00364-2.


Cellular communication network factor 2 regulates smooth muscle cell transdifferentiation and lipid accumulation in atherosclerosis.

Xu Q, Sun J, Holden C, Neto H, Wang T, Zhang C Cardiovasc Res. 2024; 120(17):2191-2207.

PMID: 39365752 PMC: 11687398. DOI: 10.1093/cvr/cvae215.


Matricellular proteins in immunometabolism and tissue homeostasis.

Eun K, Kim A, Ryu S BMB Rep. 2024; 57(9):400-416.

PMID: 38919018 PMC: 11444987.


Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth.

Zieba J, Nevarez L, Wachtell D, Martin J, Kot A, Wong S JCI Insight. 2023; 8(21.

PMID: 37796615 PMC: 10721276. DOI: 10.1172/jci.insight.171984.


References
1.
Kim B, Kim H, Jung S, Moon A, Noh D, Lee Z . A CTGF-RUNX2-RANKL Axis in Breast and Prostate Cancer Cells Promotes Tumor Progression in Bone. J Bone Miner Res. 2019; 35(1):155-166. DOI: 10.1002/jbmr.3869. View

2.
Kireeva M, Latinkic B, Kolesnikova T, Chen C, Yang G, Abler A . Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res. 1997; 233(1):63-77. DOI: 10.1006/excr.1997.3548. View

3.
Hadjiargyrou M, Ahrens W, Rubin C . Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair. J Bone Miner Res. 2000; 15(6):1014-23. DOI: 10.1359/jbmr.2000.15.6.1014. View

4.
Kivela R, Kyrolainen H, Selanne H, Komi P, Kainulainen H, Vihko V . A single bout of exercise with high mechanical loading induces the expression of Cyr61/CCN1 and CTGF/CCN2 in human skeletal muscle. J Appl Physiol (1985). 2007; 103(4):1395-401. DOI: 10.1152/japplphysiol.00531.2007. View

5.
Zhang H, Qu S, Li S, Wang Y, Li Y, Wang Y . Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells. Mol Cell Biochem. 2013; 378(1-2):39-45. DOI: 10.1007/s11010-013-1591-0. View